“AMD’s Impressive Q2 2023 Financial Results: Record-Breaking Performance and Growth”

AMD Reports Second Quarter 2023 Financial Results

AMD Reports Strong Q2 2023 Results with Revenue of $5.4 Billion SANTA CLARA, Calif., Aug. 01, 2023 — AMD (NASDAQ: AMD) announced impressive financial results for the second quarter of 2023, achieving a revenue of $5.4 billion. The company reported a gross margin of 46%, an operating loss of $20 million, net income of $27 … Read more

“Biogen’s $6.5 Billion Acquisition of Reata Strengthens Rare Disease Portfolio”

“Biogen’s $6.5 Billion Acquisition of Reata Pharmaceuticals Marks a Milestone for Rare Disease Treatments” July 28 – Biogen (BIIB.O), a renowned biotechnology firm, has made a groundbreaking move to acquire rare disease drugmaker Reata Pharmaceuticals (RETA.O) for an impressive $6.5 billion. This strategic acquisition, led by new CEO Christopher Viehbacher, aims to propel Biogen towards … Read more

“Elon Musk Hints at Further Tesla Price Cuts as Autonomous Technology Remains Challenging”

“Elon Musk’s Vision for Self-Driving Software Sparks Investor Concern as Tesla Prioritizes Sales Over Profits” I Elon Musk’s ambitious pursuit of self-driving software is leading Tesla down a path where sales take precedence over immediate profits. This strategy has potential implications for both a price war and investor apprehension. Pre-market trading on Thursday saw a … Read more